C. Michael Stein

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy”.

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3351

N/A

1.4DataRank · unranked

67 citations

Cameron D. Thomas, Craig R. Lee, Rachel Huddart, José A. G. Agúndez, Jordan Baye +13 more

CCSer2 gates dynein activity at the cell periphery

The Journal of Cell Biology(2025)10.1083/jcb.202406153

N/A

0.241DataRank · unranked

4 citations

Daytan Gibson, Ann-Marie Zheng, Wanjing Shi, John P. Gillies, C. Michael Stein +3 more